Bo Ahrén
61 – 70 of 398
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Evidence for neural contribution to islet effects of DPP-4 inhibition in mice
- Contribution to journal › Article
-
Mark
Incretin hormone receptors are required for normal beta cell development and function in female mice
- Contribution to journal › Article
-
Mark
Efficacy of lixisenatide in patients with type 2 diabetes : A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
- Contribution to journal › Article
-
Mark
Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes
- Contribution to journal › Article
-
Mark
Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
- Contribution to journal › Article
-
Mark
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus : A Post Hoc Analysis
- Contribution to journal › Article
-
Mark
Extrapancreatic contribution to glucose regulation by dipeptidyl peptidase 4 inhibition
- Contribution to journal › Scientific review
-
Mark
Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes : The adjunct two randomized trial
- Contribution to journal › Article
- 2015
-
Mark
Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
- Contribution to journal › Article
-
Mark
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
- Contribution to journal › Article